Press release
Increasing Prevalence Of Diabetes Fuels Growth In The Gastroparesis Drugs Market: An Emerging Driver Transforming The Gastroparesis Drugs Market Landscape
Gastroparesis Drugs Market Size
What Is the Projected Growth of the Gastroparesis Drugs Market?
The gastroparesis drugs market has grown strongly in recent years. It will rise from $5.39 billion in 2024 to $5.73 billion in 2025, at a CAGR of 6.3%. The growth is driven by factors such as the side effects of existing treatments and ongoing gastrointestinal motility research.
The gastroparesis drugs market is expected to see significant growth, projected to reach $7.2 billion by 2029 with a CAGR of 5.9%. This growth is driven by the increasing prevalence of diabetes, an aging population, rising awareness and diagnosis rates, higher healare spending, and government and private funding. Key trends include advancements in gastroenterology, improved diagnostic tools, technological innovations, increased research funding, and collaborative research efforts.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15812
What Are the Different Gastroparesis Drugs Market Segments?
The gastroparesis drugs market covered in this report is segmented -
1) By Drug Type: Over-the-counter (OTC) Drugs, Prescription Drugs
2) By Drug Class: Prokinetic Agents, Antiemetic Drugs, Proton Pump Inhibitors, Other Drug Classes
3) By Disease Type: Diabetic Gastroparesis, Post-Surgical Gastroparesis, Idiopathic Gastroparesis, Other Disease Types
4) By Route Of Administration: Oral, Injectables, Other Routes Of Administration
5) By Distribution Channel: Hospitals, Pharmacies, Clinics, E-commerce
Subsegments:
1) Over-the-counter (OTC) Drugs: Antacids, Anti-Nausea Medications, Antiemetics, Digestive Enzyme s
2) Prescription Drugs: Prokinetic Agents, Antiemetic Drugs, Antibiotics, Antidepressants
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15812&type=smp
What Are the Primary Drivers Shaping the Gastroparesis Drugs Market?
The growing prevalence of diabetes is expected to propel the gastroparesis drugs market. Diabetes is a long-term condition marked by elevated blood sugar levels due to insulin-related issues. Rising diabetes rates are tied to sedentary lifestyles, poor diets, urbanization, aging populations, genetic factors, and obesity. Gastroparesis drugs help alleviate symptoms like nausea and delayed gastric emptying, common among diabetic patients, thereby enhancing gastrointestinal health and life quality. For instance, in March 2024, the UK's Office for Health Improvement & Disparities stated that between March 2022 and March 2023, the percentage of type 1 diabetes patients receiving all eight care processes rose by 22%, and type 2 diabetes by 21%. Target HbA1c achievement reached a record 37.9%, according to the National Diabetes Audit. As a result, the growing diabetes burden is contributing to the expansion of the gastroparesis drugs market.
Which Companies Are Leading in the Gastroparesis Drugs Market?
Major companies operating in the gastroparesis drugs market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA., AstraZeneca plc, Abbott Laboratories, GSK plc, Takeda Pharmaceutical Inc., Teva Pharmaceutical Inc., Otsuka Pharmaceutical Co. Ltd., Bausch Health Companies Inc., Eisai Co. Ltd., Evoke Pharma Inc., Cadila Pharmaceuticals, Cipla Ltd., Neurogastrx Inc., Ipca Laboratories Ltd., ANI Pharmaceuticals Inc., Salix Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Theravance Biopharma Inc., Rhythm Pharmaceuticals Inc., Processa Pharmaceuticals Inc., Aclipse Therapeutics LLC, ETX Pharma Inc.
What Trends Are Driving Growth in The Gastroparesis Drugs Market?
Leading players in the gastroparesis drugs industry are concentrating on the launch of groundbreaking medicines like Gimoti (metoclopramide) nasal spray to secure a competitive advantage. This drug is utilized to manage gastroparesis symptoms in adults by accelerating gastric emptying through enhanced gastrointestinal mobility. Unlike other treatments, it doesn't pass through the digestive tract and is instead directly assimilated into the bloodstream via the nasal lining. As an example, in April 2022, Evoke Pharma Inc., a pharmaceutical company based in the United States, proclaimed the U.S. Food and Drug Administration (FDA) gave exclusivity for their new drug, GIMOTI (metoclopramide) nasal spray. With the protection afforded by the Hatch-Waxman Act, this exclusivity will shield the product from generic competitors for three years from its original approval, giving Evoke sole rights to its marketing.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/gastroparesis-drugs-global-market-report
What Are the Top Revenue-Generating Geographies in the Gastroparesis Drugs Market?
North America was the largest region in the gastroparesis drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroparesis drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Gastroparesis Drugs Market?
2. What is the CAGR expected in the Gastroparesis Drugs Market?
3. What Are the Key Innovations Transforming the Gastroparesis Drugs Industry?
4. Which Region Is Leading the Gastroparesis Drugs Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Increasing Prevalence Of Diabetes Fuels Growth In The Gastroparesis Drugs Market: An Emerging Driver Transforming The Gastroparesis Drugs Market Landscape here
News-ID: 4039218 • Views: …
More Releases from The Business Research Company
Global Acrylic Powder Market Worth $77.43 Billion by 2029, Growing at 7.5% CAGR
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Acrylic Powder Market Outlook: What Size And CAGR Are Anticipated By 2025?
In recent years, the market size of acrylic powder has experienced significant growth. It is projected to expand from $54.48 billion in 2024 to $57.94 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%. Factors…
Toluene Derivatives Industry to Achieve $8.45 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Toluene Derivatives Market Grow by 2025 in Terms of Size and Growth?
In recent times, the market size of toluene derivatives has considerably grown. The market is projected to rise from $5.98 billion in 2024 to $6.4 billion in 2025, with a compound annual growth rate (CAGR) of 7.0%.…
Sulfur Dioxide Market on Path to Hit $7.07 Billion by 2029 at 3.9% CAGR
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Sulfur Dioxide Market Outlook: What Size And CAGR Are Anticipated By 2025?
The sulfur dioxide market has seen a consistent growth in its size over the past few years. Projected to expand from $5.89 billion in 2024 to $6.08 billion in 2025, it is speculated to increase at a compound…
Release Agents Market to Surpass $1.35 Billion by 2029 | Key Trends & Insights
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Release Agents Market Grow by 2025 in Terms of Size and Growth?
The market size of release agents has seen significant growth in recent years. The market is projected to expand from a value of $1.06 billion in 2024 to $1.11 billion in 2025, with a compound annual growth…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
